PATIENT ASSISTANCE

As part of the company’s commitment to the UCD community, Ucyclyd Pharma, Inc. has established a program through which qualified UCD patients with demonstrated financial need can receive BUPHENYL^® (sodium phenylbutyrate) Tablets and Powder at no cost. Participating patients receive their medication via mail and are billed for shipping charges.

The National Organization of Rare Diseases (NORD) administers the BUPHENYL patient assistance program. Criteria for participation include:

• A diagnosis of a urea cycle disorder involving deficiencies of carbamyl phosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (ASS)
  
• US residency
  
• Demonstrated financial need, which takes into account income as well as overall healthcare costs

To learn more about the BUPHENYL patient assistance program or to get an application, call the toll-free hotline at 1.800.711.0811. NORD will review your completed application and make a decision on your eligibility for the program.

Click here for important safety information

Click here for Full Prescribing Information